Shares of Merck KGaA (MKGAY.PK) were losing around 5 percent in the morning trading in Germany after the drug major reported Thursday that its fiscal 2017 EBITDA, a key earnings metric, and margin declined, despite higher sales. Net profit, however, climbed with positive U.S. tax reform impact. Further, the company warned about fiscal 2018.
from RTT - Earnings http://ift.tt/2FB2ZeY
via IFTTT
No comments:
Post a Comment